Search details
1.
Structural evolution of glycan recognition by a family of potent HIV antibodies.
Cell
; 159(1): 69-79, 2014 Sep 25.
Article
in English
| MEDLINE | ID: mdl-25259921
2.
Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.
Immunity
; 44(4): 939-50, 2016 Apr 19.
Article
in English
| MEDLINE | ID: mdl-27067056
3.
A broad and potent neutralization epitope in SARS-related coronaviruses.
Proc Natl Acad Sci U S A
; 119(29): e2205784119, 2022 07 19.
Article
in English
| MEDLINE | ID: mdl-35767670
4.
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.
Immunity
; 43(6): 1053-63, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26682982
5.
X-ray structures of the hexameric building block of the HIV capsid.
Cell
; 137(7): 1282-92, 2009 Jun 26.
Article
in English
| MEDLINE | ID: mdl-19523676
6.
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.
Proc Natl Acad Sci U S A
; 112(38): 11947-52, 2015 Sep 22.
Article
in English
| MEDLINE | ID: mdl-26372963
7.
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.
Proc Natl Acad Sci U S A
; 111(49): 17624-9, 2014 Dec 09.
Article
in English
| MEDLINE | ID: mdl-25422458
8.
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
Acta Crystallogr D Biol Crystallogr
; 71(Pt 10): 2099-108, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26457433
9.
A broad and potent neutralization epitope in SARS-related coronaviruses.
bioRxiv
; 2022 Mar 14.
Article
in English
| MEDLINE | ID: mdl-35313576
10.
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies.
Science
; 375(6582): 782-787, 2022 02 18.
Article
in English
| MEDLINE | ID: mdl-35076281
11.
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target.
Sci Adv
; 6(30): eabb5642, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32754640
12.
Structural basis of a public antibody response to SARS-CoV-2.
bioRxiv
; 2020 Jun 09.
Article
in English
| MEDLINE | ID: mdl-32577642
13.
Structural basis of a shared antibody response to SARS-CoV-2.
Science
; 369(6507): 1119-1123, 2020 08 28.
Article
in English
| MEDLINE | ID: mdl-32661058
14.
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies.
Sci Adv
; 5(1): eaav1882, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30613781
15.
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence.
Nat Commun
; 10(1): 2355, 2019 05 29.
Article
in English
| MEDLINE | ID: mdl-31142746
16.
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.
J Exp Med
; 214(9): 2573-2590, 2017 Sep 04.
Article
in English
| MEDLINE | ID: mdl-28847869
17.
Cloning and expression of multiple integral membrane proteins from Mycobacterium tuberculosis in Escherichia coli.
Protein Sci
; 14(1): 148-58, 2005 Jan.
Article
in English
| MEDLINE | ID: mdl-15608119
18.
Hepatitis C virus E2 envelope glycoprotein core structure.
Science
; 342(6162): 1090-4, 2013 Nov 29.
Article
in English
| MEDLINE | ID: mdl-24288331
19.
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
Nat Struct Mol Biol
; 20(7): 796-803, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23708606
20.
Disulfide bond stabilization of the hexameric capsomer of human immunodeficiency virus.
J Mol Biol
; 401(5): 985-95, 2010 Sep 03.
Article
in English
| MEDLINE | ID: mdl-20600115